Massimo Clementi

16.1k total citations
325 papers, 9.8k citations indexed

About

Massimo Clementi is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Massimo Clementi has authored 325 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Epidemiology, 106 papers in Infectious Diseases and 79 papers in Hepatology. Recurrent topics in Massimo Clementi's work include HIV Research and Treatment (75 papers), Hepatitis C virus research (74 papers) and Hepatitis B Virus Studies (59 papers). Massimo Clementi is often cited by papers focused on HIV Research and Treatment (75 papers), Hepatitis C virus research (74 papers) and Hepatitis B Virus Studies (59 papers). Massimo Clementi collaborates with scholars based in Italy, United States and France. Massimo Clementi's co-authors include Nicasio Mancini, Aldo Manzin, Roberto Burioni, Stefano Menzo, Claude Stoll, Filippo Canducci, Nicola Clementi, Pietro E. Varaldo, Laura Solforosi and Ester Garne and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Massimo Clementi

320 papers receiving 9.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Massimo Clementi 3.7k 2.8k 1.9k 1.8k 1.7k 325 9.8k
Guido Antonelli 2.5k 0.7× 2.3k 0.8× 1.0k 0.5× 900 0.5× 695 0.4× 371 7.4k
Maria Rosaria Capobianchi 2.8k 0.8× 4.6k 1.7× 1.6k 0.8× 1.4k 0.8× 1.6k 0.9× 396 9.5k
Judith Breuer 7.6k 2.0× 2.1k 0.7× 1.3k 0.7× 1.8k 1.0× 431 0.2× 478 12.5k
Lindsey R. Baden 5.0k 1.3× 5.9k 2.1× 700 0.4× 1.1k 0.6× 985 0.6× 230 10.7k
Pierre Lebon 3.6k 1.0× 2.7k 1.0× 1.4k 0.7× 1.3k 0.7× 491 0.3× 225 9.3k
Robert F. Garry 1.9k 0.5× 3.2k 1.2× 1.0k 0.5× 1.6k 0.9× 560 0.3× 227 7.1k
Geert Leroux‐Roels 6.9k 1.8× 2.2k 0.8× 658 0.3× 1.8k 1.0× 4.6k 2.7× 297 11.5k
Juan Berenguer 7.0k 1.9× 3.4k 1.3× 1.1k 0.6× 563 0.3× 5.5k 3.2× 467 13.7k
Mark J. DiNubile 4.7k 1.3× 4.6k 1.7× 1.1k 0.6× 786 0.4× 2.9k 1.7× 160 9.2k
Keith R. Jerome 4.9k 1.3× 5.4k 2.0× 683 0.4× 2.6k 1.4× 437 0.3× 308 13.5k

Countries citing papers authored by Massimo Clementi

Since Specialization
Citations

This map shows the geographic impact of Massimo Clementi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Clementi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Clementi more than expected).

Fields of papers citing papers by Massimo Clementi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Clementi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Clementi. The network helps show where Massimo Clementi may publish in the future.

Co-authorship network of co-authors of Massimo Clementi

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Clementi. A scholar is included among the top collaborators of Massimo Clementi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Clementi. Massimo Clementi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spagnuolo, Vincenzo, Laura Galli, Andrea Poli, et al.. (2022). Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study. Drug Design Development and Therapy. Volume 16. 3645–3654. 3 indexed citations
2.
Severa, Martina, Roberta A. Diotti, Marilena P. Etna, et al.. (2021). Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathogens. 17(9). e1009878–e1009878. 59 indexed citations
3.
Castelli, Matteo, Andreina Baj, Elena Criscuolo, et al.. (2021). Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy. Viruses. 13(8). 1514–1514. 9 indexed citations
4.
Velázquez‐Moctezuma, Rodrigo, Matteo Castelli, Nicola Clementi, et al.. (2021). Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies. Vaccines. 9(3). 291–291. 12 indexed citations
5.
Pederzoli, Filippo, Roberto Ferrarese, Irene Locatelli, et al.. (2020). Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients. European Urology Oncology. 3(6). 784–788. 68 indexed citations
6.
Sautto, Giuseppe A., Karin Wisskirchen, Nicola Clementi, et al.. (2015). Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein. Gut. 65(3). 512–523. 71 indexed citations
7.
Sautto, Giuseppe A., Nicasio Mancini, Giacomo Gorini, Massimo Clementi, & Roberto Burioni. (2013). Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections. BioMed Research International. 2013. 1–21. 15 indexed citations
8.
Scagnolari, Carolina, Carla Selvaggi, Alessandra Pierangeli, et al.. (2011). Pandemic 2009 H1N1 Influenza Virus Is Resistant to the Antiviral Activity of Several Interferon Alpha Subtypes. Journal of Interferon & Cytokine Research. 31(6). 475–479. 9 indexed citations
9.
Gianotti, Nicola, Elena Seminari, Adriano Lazzarin, et al.. (2005). Redistribution of Human Immunodeficiency Virus Type 1 Variants Resistant to Protease Inhibitors after a Protease Inhibitor-Sparing Regimen. AIDS Research and Human Retroviruses. 21(6). 545–554. 2 indexed citations
10.
Hasson, Hamid, et al.. (2004). The introduction of the fusion inhibitors in the HAART-regimens.. Università Politecnica delle Marche (Università Politecnica delle Marche). 3 indexed citations
11.
Lodrini, S., Sabrina Bagaglio, Filippo Canducci, et al.. (2004). Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.. PubMed. 17(2). 198–204. 10 indexed citations
12.
Menzo, Stefano, Antonella Castagna, Alessia Monachetti, et al.. (2004). Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.. PubMed. 27(2 Suppl 1). 51–61. 16 indexed citations
13.
Vecchi, Manuela, et al.. (2004). Genotypic and Phenotypic Correlates of the HIV Type 1 env Gene Evolution in Infected Children with Discordant Response to Antiretroviral Therapy. AIDS Research and Human Retroviruses. 20(12). 1306–1313. 8 indexed citations
14.
Boeri, Enzo, Nicola Gianotti, Filippo Canducci, et al.. (2003). Evolutionary Characteristics of HIV Type 1 Variants Resistant to Protease Inhibitors in the Absence of Drug-Selective Pressure. AIDS Research and Human Retroviruses. 19(12). 1151–1153. 16 indexed citations
15.
Mastroiacovo, P, Teresa Mazzone, Antonio Addis, et al.. (1999). High vitamin A intake in early pregnancy and major malformations: A multicenter prospective controlled study. Teratology. 59(1). 7–11. 44 indexed citations
16.
Sagliocca, Luciano, Grazia Tosone, Vincenzo Guadagnino, et al.. (1998). Sexual Transmission of Hepatitis C Virus and Prevention with Intramuscular Immunoglobulin. AIDS Patient Care and STDs. 12(8). 611–618. 1 indexed citations
17.
Silvestri, Guido, et al.. (1998). Early increase of CD4+ CD45RA+ and CD4+ CD95− cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clinical & Experimental Immunology. 111(1). 3–11. 15 indexed citations
18.
Andreoné, Pietro, Carmela Cursaro, Annagiulia Gramenzi, et al.. (1993). Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis. IRIS UNIMORE (University of Modena and Reggio Emilia). 9(4). 201–205. 4 indexed citations
19.
Clementi, Massimo, et al.. (1979). [Epidemiologic study on the distribution of rubella antibodies in the female population of the Marches].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 70(45). 3121–3. 1 indexed citations
20.
Clementi, Massimo. (1978). [Meningitis caused by Echovirus 25].. PubMed. 69(57). 3941–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guido Antonelli Breakdown of academic impact, for papers by Maria Rosaria Capobianchi Breakdown of academic impact, for papers by Judith Breuer Breakdown of academic impact, for papers by Lindsey R. Baden Breakdown of academic impact, for papers by Pierre Lebon Breakdown of academic impact, for papers by Robert F. Garry Breakdown of academic impact, for papers by Geert Leroux‐Roels Breakdown of academic impact, for papers by Juan Berenguer Breakdown of academic impact, for papers by Mark J. DiNubile Breakdown of academic impact, for papers by Keith R. Jerome
Rankless by CCL
2026